Fig. 3From: Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells a Risk difference with stem cell therapy compared to control and interventions. b Risk difference with stem cell therapy compared to control and interventions by ulcer size and age group. BMMNCs bone marrow-derived mononuclear cells, BMMSCs bone marrow-derived mesenchymal stem cells, BMTRCs bone marrow-enriched tissue repair cells, CI confidence interval, M-H Mantel-HaenszelBack to article page